comparemela.com

Latest Breaking News On - Smithkline plc - Page 13 : comparemela.com

Chordoma Disease Therapeutics Market to Reach US$ 8,339 2 Million at a CAGR of 6 7% by 2027

Chordoma is a rare type of cancer, which occurs in the spine region or from the base of the skull to the tailbone.

United statesUnited kingdomSouth koreaBristol myers squibbInternational economy analysisPremium researchGlaxosmithkline plcMerck co incChordoma disease therapeutics china market development trendAstellas pharma incPfizer incNovartis internationalBoehringer ingelheim international gmbDevelopment trend of chordoma disease therapeutics industryBayer agChordoma disease therapeutics international market development history

Herpes treatment market to grow by 4 05% Y-O-Y in 2023; Increasing prevalence of herpes infection will drive growth

/PRNewswire/ Herpes treatment market insights - Vendors: 15+, including AbbVie Inc., AiCuris Anti infective Cures AG, Aurobindo Pharma Ltd., Avet.

United statesUnited kingdomEli lillyJesse maidaCipla ltdAurobindo pharma ltdGlaxosmithkline plcTechnavio researchSun pharmaceutical industries ltdZeelab laboratories ltdGilead sciences incTeva pharmaceutical industries ltdAbbvie incCadila healthcare ltdMaruho coBausch health co inc

Addisons disease therapeutics market size to increase by USD 442 million: 41% growth to originate from North America

/PRNewswire/ The Addisons Disease Therapeutics Market by Therapy, End-user, and Geography - Forecast and Analysis 2023-2027 report has been published by.

United statesUnited kingdomEli lillyJesse maidaGlaxosmithkline plcTechnavio researchAkorn operating coMerck coBiogen incPfizer incTakeda pharmaceutical coBrowse for technavio health care researchBoehringer ingelheim international gmbBristol myers squibb coNeurocrine biosciences incBayer ag

Sinusitis drugs market size to increase by USD 801 39 million: 40% growth to originate from North America

/PRNewswire/ The Sinusitis Drugs Market by Product, Disease Type, and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio..

United statesUnited kingdomJesse maidaCipla ltdAurobindo pharma ltdGlaxosmithkline plcTechnavio researchDr reddys laboratories ltdSun pharmaceutical industries ltdTeva pharmaceutical industries ltdPfizer incAbbvie incBrowse for technavio health care researchAlembic pharmaceuticals ltdBionpharma incBayer ag

Sexually transmitted disease (STD) testing market size to grow by USD 29,988 27 Million: Increasing prevalence of STDs remains key growth driver

/PRNewswire/ The global sexually transmitted disease (STD) testing market size is set to grow by USD 29,988.27 million from 2022 to 2027, according to.

United statesUnited kingdomAdvacare pharmaJesse maidaOk biotech coGlaxosmithkline plcTechnavio researchEverlywell incRaybiotech life incProduct serviceInovio pharmaceuticals incGilead sciences incAccubiotech coAbbvie incBiotech incHologic inc

vimarsana © 2020. All Rights Reserved.